Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 12-2012 | |
| Sales | 5,298 | 5,001 | 0 | 10,788 | 0 |
| Gross Profit | 5,298 | 5,001 | N/A | 10,788 | N/A |
| Operating Expenses | 3,920 | 3,969 | 0 | 4,269 | 0 |
| Operating Income | 1,378 | 1,032 | N/A | 6,519 | N/A |
| Interest Expense | 0 | 0 | 0 | 15 | 0 |
| Other Income | -148 | 341 | 0 | -126 | 0 |
| Pre-tax Income | 1,230 | 1,373 | 0 | 6,378 | 0 |
| Net Income Continuous | 1,230 | 1,373 | N/A | 6,378 | N/A |
| Net Income | $1,230 | $1,373 | $N/A | $6,378 | $N/A |
| EPS Basic Total Ops | N/A | N/A | N/A | 0.99 | N/A |
| EPS Basic Continuous Ops | 0.91 | 1.02 | N/A | 4.77 | N/A |
| EPS Diluted Total Ops | N/A | N/A | N/A | 0.63 | N/A |
| EPS Diluted Continuous Ops | 0.91 | 1.02 | N/A | 3.07 | N/A |
| EBITDA(a) | $1,553 | $1,207 | $N/A | $6,519 | $N/A |